MENU
+Compare
ANVS
Stock ticker: NYSE
AS OF
Jul 17, 04:59 PM (EDT)
Price
$2.83
Change
+$0.09 (+3.28%)
Capitalization
53.39M

ANVS Annovis Bio Forecast, Technical & Fundamental Analysis

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases... Show more

ANVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ANVS with price predictions
Jul 16, 2025

ANVS's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for ANVS turned positive on July 10, 2025. Looking at past instances where ANVS's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 10, 2025. You may want to consider a long position or call options on ANVS as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

ANVS moved above its 50-day moving average on June 30, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ANVS advanced for three days, in of 259 cases, the price rose further within the following month. The odds of a continued upward trend are .

ANVS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 10-day RSI Indicator for ANVS moved out of overbought territory on June 10, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ANVS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ANVS entered a downward trend on July 09, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.171) is normal, around the industry mean (17.671). P/E Ratio (0.000) is within average values for comparable stocks, (59.020). ANVS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.459). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (273.095).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ANVS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ANVS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ANVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ANVS is expected to report earnings to rise 25.97% to -40 cents per share on August 13

Annovis Bio ANVS Stock Earnings Reports
Q2'25
Est.
$-0.40
Q1'25
Beat
by $0.06
Q4'24
Missed
by $0.11
Q3'24
Missed
by $0.46
Q2'24
Beat
by $0.19
The last earnings report on May 13 showed earnings per share of -31 cents, beating the estimate of -37 cents. With 134.49K shares outstanding, the current market capitalization sits at 53.39M.
A.I. Advisor
published General Information

General Information

a developer of drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
101 Lindenwood Drive
Phone
+1 484 875-3192
Employees
6
Web
https://www.annovisbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BNSOF2.20N/A
N/A
Bonso Electronics International, Inc.
AVBH21.53N/A
N/A
Avidbank Holdings, Inc.
TKCBY22.95N/A
N/A
Tokai Carbon Company Ltd.
PLWN575.00N/A
N/A
Pinelawn Cemetery
UNIRF4.28N/A
N/A
Unibail Rodamco

ANVS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ANVS has been loosely correlated with ADXN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ANVS jumps, then ADXN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANVS
1D Price
Change %
ANVS100%
+2.24%
ADXN - ANVS
43%
Loosely correlated
-1.89%
ATXS - ANVS
39%
Loosely correlated
+0.32%
RXRX - ANVS
38%
Loosely correlated
+3.26%
ZURA - ANVS
38%
Loosely correlated
-0.77%
ERAS - ANVS
38%
Loosely correlated
+2.13%
More